台湾で初の変異型M痘の海外流入事例、疾管署はリスクのある人々にワクチン完全接種を呼びかけ
台湾の疾病管制署は、タイからの渡航者から国内初となるM痘ウイルスのクレードI Ib亜系統の輸入症例を確認したと発表しました。当局はリスクのある人々に対し、2回接種のワクチンを速やかに完了するよう呼びかけています。
📋 記事の処理履歴
- 📰 発表: 2026年5月19日 16:39
- 🔍 収集: 2026年5月19日 17:01(発表から22分後)
- 🤖 AI分析完了: 2026年5月19日 19:25(収集から2時間23分後)
よくある質問
What new Mpox development was announced in Taiwan?
Taiwan announced its first detected case of the Mpox clade I Ib substrain, a new variant for the country, found in a person who had traveled to Thailand.
How many new Mpox cases were reported in May?
Two new cases were reported in May: one domestic case and one imported case from Thailand.
What is the significance of this new imported case?
It is the first time the clade I Ib virus strain has been identified in Taiwan since Mpox became a notifiable infectious disease in 2022; all previous cases were of the clade II strain.
What is the Taiwan CDC's primary recommendation?
The CDC strongly advises all eligible individuals, especially those with high-risk behaviors, to complete the two-dose Mpox vaccination course as soon as possible.
How effective is the Mpox vaccine according to the article?
A complete two-dose vaccination provides about 90% protection against the Mpox virus, while a single dose offers only 40% to 80% protection. The vaccine is effective against both clade I and clade II strains.